Superba Krill Receives FDA NDI Notification
To earn the NDI status, Aker BioMarine submitted human and animal data on scientific research and toxicology for Superba.
Superba Krill Oil has received New Dietary Ingredient (NDI) notification from FDA, according to its supplier Aker BioMarine (Oslo, Norway).
Krill oil is an emerging source of marine omega-3s eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and astaxanthin. Due to its low level on the food chain, krill is marketed as a nutrition source with low accumulation of heavy metals.
To earn the NDI status, Aker BioMarine submitted human and animal data on scientific research and toxicology for Superba.
“Krill oil has been legally marketed in the United States for many years,” says Nils Hoem, PhD, chief scientist at Aker BioMarine. “However, in addition to our GRAS submission already in place, we felt that our choice to submit information to FDA for review via the NDI process fully validates our safety dossier. Further, our unique manufacturing process uses ethanol, a more internationally accepted solvent.”
Superba Krill Oil is also the only krill ingredient bearing Marine Stewardship Council (MSC) Certification for sustainable fishing practices.
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
